Skip to main content
SpringerLink
Log in

Mammalian Heparanase: Molecular Properties, Inhibition and Involvement in Tumor Metastasis and Angiogenesis

  • Chapter
Proteases and Their Inhibitors in Cancer Metastasis

Part of the book series: Cancer Metastasis — Biology and Treatment ((CMBT,volume 4))

  • 109 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aviezer D, Hecht D, Safran M, Eisinger M, David G, Yayon A. Perlecan basal lamina proteoglycan promotes basic fibroblast growth factor-receptor binding, mitogenesis and angiogenesis. Cell 1994; 79: 1005–1013.

    Article  CAS  PubMed  Google Scholar 

  • Bame KJ, Hassall A, Sanderson C, Venkatesan I, Sun C. Partial purification of heparanase activities in Chinese hamster ovary cells: evidence for multiple intracellular heparanases. Biochem J 1998; 336: 191–200.

    CAS  PubMed  Google Scholar 

  • Bartlett MR, Cowden WB, Parish CR. Differential effects of the anti-inflammatory compounds heparin, mannose-6-phosphate and castanospermine on degradation of the vascular basement membrane by leukocytes, endothelial cells and platelets. J Leukoc Biol 1995; 57: 207–213.

    CAS  PubMed  Google Scholar 

  • Bernfield, M Gotte, M Park, PW Reizes, O Fitzgerald ML, Lincecum J, Zako M. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 1999; 68: 729–777.

    Article  CAS  PubMed  Google Scholar 

  • Bitan M, Polliack A, Zecchina G, Nagler A, Friedmann Y, Nadav L, Deutsch V, Pecker I, Eldor A, Vlodavsky I, Katz B-Z. Heparanase expression in human leukemias is restricted to acute myeloid leukemias. Exp Hematol 2002; 30: 34–41.

    Article  CAS  PubMed  Google Scholar 

  • Cardin AD, Demeter DA, Weintraub HJ, Jackson RL. Molecular design and modeling of protein-heparin interactions. Methods Enzymol 1991; 203: 556–583.

    Article  CAS  PubMed  Google Scholar 

  • Chang Z, Meyer K, Rapraeger AC, Friedl A. Differential ability of heparan sulfate proteoglycans to assemble the fibroblast growth factor receptor complex in situ. FASEB J 2000; 14: 137–144.

    CAS  PubMed  Google Scholar 

  • Coombe DR, Parish CR, Ramshaw IA, Snowden JM. Analysis of the inhibition of tumour metastasis by sulphated polysaccharides. Int J Cancer 1987; 39: 82–88.

    Article  CAS  PubMed  Google Scholar 

  • David G. Integral membrane heparan sulfate proteoglycans. FASEB J 1993; 7: 1023–1030.

    CAS  PubMed  Google Scholar 

  • Dempsey LA, Plummer TB, Coombes SL, Platt JL. Heparanase expression in invasive trophoblasts and acute vascular damage. Glycobiology 2000; 10: 467–475

    Article  CAS  PubMed  Google Scholar 

  • De Vouge MW, Yamazaki A, Bennett SA, Chen JH, Shwed PS, Couture C, Birnboim HC. Immunoselection of GRP94/endoplasmin from a KNRK cell-specific lambda gt11 library using antibodies directed against a putative heparanase amino-terminal peptide. Int J Cancer 1994; 56: 286–294.

    Article  PubMed  Google Scholar 

  • Elkin M, Ishai-Michaeli R, Friedmann Y, Papo O, Pecker I, Vlodavsky I. Heparanase as mediator of angiogenesis: mode of action. FASEB J 2001; 15: 1661–1663.

    CAS  PubMed  Google Scholar 

  • Ernst S, Langer R, Cooney CL, Sasisekharan R. Enzymatic degradation of glycosaminoglycans. Crit Rev Biochem Mol Biol 1995; 30: 387–444.

    Article  CAS  PubMed  Google Scholar 

  • Fairbanks MB, Mildner AM, Leone JW, Cavey GS, Mathews WR, Drong RF, Slightom JL, Bienkowski MJ, Smith CW, Bannow CA, Heinrikson RL. Processing of the human heparanase precursor and evidence that the active enzyme is a heterodimer. J Biol Chem 1999; 274: 29587–29590.

    Article  CAS  PubMed  Google Scholar 

  • Finkel E. Potential target found for anti-metastasis drugs. Science 1999; 285: 33–34.

    Article  CAS  PubMed  Google Scholar 

  • Folkman J, Shing Y. Control of angiogenesis by heparin and other sulfated polysaccharides. Adv Exp Med Biol 1992; 313: 355–364.

    CAS  PubMed  Google Scholar 

  • Freeman C, Parish CR. Human platelet heparanase: purification characterization and catalytic activity. Biochem J 1998; 330: 1341–1350.

    CAS  PubMed  Google Scholar 

  • Freeman C, Browne AM, Parish CR. Evidence that platelet and tumour heparanases are similar enzymes. Biochem J 1999; 342: 361–368.

    Article  CAS  PubMed  Google Scholar 

  • Friedmann Y, Vlodavsky I, Aingorn H, Aviv A, Peretz T, Pecker I, Pappo O. Expression of heparanase in normal dysplastic and Neoplastic human colon mucosa and stroma. Am J Pathol 2000; 108: 341–347.

    Google Scholar 

  • Gilat D, Hershkoviz R, Goldkorn I, Cahalon L, Korner G, Vlodavsky I, Lider O. Molecular behavior adapts to context: heparanase functions as an extracellular matrix-degrading enzyme or as a T cell adhesion molecule depending on the local pH. J Exp Med 1995; 181, 1929–1934.

    Article  CAS  PubMed  Google Scholar 

  • Gohji K, Hirano H, Okamoto M, Kitazawa S, Toyoshima M, Dong J, Katsuoka Y, Nakajima M. Expression of three extracellular matrix degradative enzymes in bladder cancer. Int J Cancer 2001; 95: 295–301.

    Article  CAS  PubMed  Google Scholar 

  • Goldshmidt O, Nadav L, Aingorn H, Irit C, Feinstein N, Ilan N, Zamir E, Geiger B, Vlodavsky I, Katz BZ. Human heparanase is localized within lysosomes in a stable form. Exptl Cell Res 2002; 281: 50–62.

    Article  CAS  PubMed  Google Scholar 

  • Goldshmidt O, Zcharia E, Abramovitch R, Metzger S, Aingorn H, Friedmann Y, Mitrani E, Vlodavsky I. Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis. Proc Natl Acad Sci USA 2002; 99: 10031–10036.

    Article  CAS  ADS  PubMed  Google Scholar 

  • Goldshmidt O, Zcharia E, Aingorn H, Guatta-Rangini Z, Atzmon R, Michal I, Pecker I, Mitrani E, Vlodavsky I. Secretion and expression pattern of human and chicken heparanase are determined by their signal peptide sequences. J Biol Chem 2001; 276: 29178–29187.

    Article  CAS  PubMed  Google Scholar 

  • Goshen R, Hochberg AA, Korner G, Levy E, Ishai-Michaeli R, Elkin M, de Groot N, Vlodavsky I. Purification and characterization of placental heparanase and its expression by cultured cytotrophoblasts. Mol Hum Reprod 1996; 2: 679–684.

    Article  CAS  PubMed  Google Scholar 

  • Graham LD, Underwood PA. Comparison of the heparanase enzymes from mouse melanoma cells, mouse macrophages and human platelets. Biochem Mol Biol Int 1996; 39: 563–571.

    CAS  PubMed  Google Scholar 

  • Green D, Hull RD, Brant R, Pineo GF. Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin [letter]. Lancet 1992; 339: 1476.

    Article  CAS  PubMed  Google Scholar 

  • Hoogewerf AJ, Leone JW, Reardon IM, Howe WJ, Asa D, Heinrikson RL, Ledbetter SR. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes. J Biol Chem 1995; 270: 3268–3277.

    Article  CAS  PubMed  Google Scholar 

  • Hulett MD, Freeman C, Hamdorf BJ, Baker RT, Harris MJ, Parish CR. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med 1999; 5: 803–809.

    Article  CAS  PubMed  Google Scholar 

  • Hulett MD, Hornbu JR, Ohms SJ, Zuegg J, Freeman C, Gready JE, Parish CR. Identification of active-site of the pro-metastatic endoglycisidase heparanase. Biochemistry 2000; 39: 15659–15667.

    Article  CAS  PubMed  Google Scholar 

  • Iozzo RV. Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 1998; 67: 609–652.

    Article  CAS  PubMed  Google Scholar 

  • Jin L, Nakajima M, Nicolson GL. Immunochemical localization of heparanase in mouse and human melanomas. Int J Cancer 1990; 45: 1088–1095.

    Article  CAS  PubMed  Google Scholar 

  • Kjellen L, Lindahl U. Proteoglycans: structures and interactions. Annu Rev Biochem 1991; 60: 443–475.

    Article  CAS  PubMed  Google Scholar 

  • Kjellen L, Pertoft H, Oldberg A, Hook M. Oligosaccharides generated by an endoglucuronidase are intermediates in the intracellular degradation of heparan sulfate proteoglycans. J Biol Chem 1985; 260: 8416–8422.

    CAS  PubMed  Google Scholar 

  • Klein U, Von Figura K. Partial purification and characterization of heparan sulfate specific endoglucuronidase. Biochem Biophys Res Commun 1976; 73: 569–576.

    Article  CAS  PubMed  Google Scholar 

  • Kleiner DE Jr, Stetler-Stevenson WG. Structural biochemistry and activation of matrix metalloproteases. Curr Opin Cell Biol 1993; 5: 891–897.

    Article  CAS  PubMed  Google Scholar 

  • Koenig A, Norgard-Sumnicht K, Linhardt R, Varki A. Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents. J Clin Invest 1998; 101: 877–889.

    Article  CAS  PubMed  Google Scholar 

  • Koliopanos A, Friess H, Kleeff J, Shi X, Liao Q, Pecker I, Vlodavsky I, Zimmermann A, Büchler MW. Heparanase expression in primary and metastatic pancreatic cancer. Cancer Res 2001; 61: 4655–4659.

    CAS  PubMed  Google Scholar 

  • Kussie PH, Hulmes JD, Ludwig DL, Patel S, Navarro EC, Seddon AP, Giorgio NA, Bohlen P. Cloning and functional expression of a human heparanase gene. Biochem Biophys Res Commun 1999; 261: 183–187.

    Article  CAS  PubMed  Google Scholar 

  • Liotta LA, Rao CN, Barsky SH. Tumor invasion and the extracellular matrix. Lab Invest 1983; 49: 636–649.

    CAS  PubMed  Google Scholar 

  • Marchetti D, Liu S, Spohn WC, Carson DD. Heparanase and a synthetic peptide of heparan sulfate-interacting protein recognize common sites on cell surface and extracellular matrix heparan sulfate. J Biol Chem 1997; 272: 15891–15897.

    Article  CAS  PubMed  Google Scholar 

  • Matzner Y, Vlodavsky I, Bar-Ner M, Ishai-Michaeli R, Tauber AI. Subcellular localization of heparanase in human neutrophils. J Leukoc Biol 1992; 51: 519–524.

    CAS  PubMed  Google Scholar 

  • Miao HQ, Elkin M Aingorn E, Ishai-Michaeli R, Stein CA, Vlodavsky I. Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides. Int J Cancer 1999; 83: 424–431.

    Article  CAS  PubMed  Google Scholar 

  • Mishima T, Murata J, Toyoshima M, Fujii H, Nakajima M, Hayashi T, Kato T, Saiki I. Inhibition of tumor invasion and metastasis by calcium spirulan (Ca-SP), a novel sulfated polysaccharide derived from a blue-green alga Spirulina platensis. Clin Exp Metastasis 1998; 16: 541–550.

    Article  CAS  PubMed  Google Scholar 

  • Mollinedo F, Nakajima M, Llorens A, Barbosa E, Callejo S, Gajate C, Fabra A. Major co-localization of the extracellular-matrix degradative enzymes heparanase and gelatinase in tertiary granules of human neutrophils. Biochem J 1997; 327: 917–923.

    CAS  PubMed  Google Scholar 

  • Nadav L, Yacoby-Zeevi O, Zamir E, Pecker I, Ilan N, Geiger B, Eldor A, Vlodavsky I, Katz BZ. Activation, processing and trafficking of extracellular heparanase by primary human fibroblasts. J Cell Sci 2002; 115: 2179–2187.

    CAS  PubMed  Google Scholar 

  • Nakajima M, DeChavigny, A, Johnson CE, Hamada J, Stein CA, Nicolson GL. Suramin. A potent inhibitor of melanoma, heparanase and invasion. J Biol Chem 1991; 266: 9661–9666.

    CAS  PubMed  Google Scholar 

  • Nakajima M, Irimura T, Nicolson GL. Heparanases and tumor metastasis. J Cell Biochem 1988; 36: 157–167.

    Article  CAS  PubMed  Google Scholar 

  • Oosta GM, Favreau LV, Beeler DL, Rosenberg RD. Purification and properties of human platelet heparitinase. J Biol Chem 1982; 257: 11249–11255.

    CAS  PubMed  Google Scholar 

  • Parish CR, Coombe DR, Jakobsen KB, Bennett FA, Underwood PA. Evidence that sulphated polysaccharides inhibit tumour metastasis by blocking tumour-cell-derived heparanases. Int J Cancer 1987; 40: 511–518.

    Article  CAS  PubMed  Google Scholar 

  • Parish CR, Freeman C, Brown KJ, Francis DJ, Cowden WB. Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity. Cancer Res 1999; 59: 3433–3441.

    CAS  PubMed  Google Scholar 

  • Parish CR, Freeman C, Hulett MD. Heparanase: a key enzyme involved in cell invasion. Biochem Biophys Acta 2001; 1471: M99–M108.

    CAS  PubMed  Google Scholar 

  • Pikas DS, Li JP, Vlodavsky I, Lindahl U. Substrate specificity of heparanases from human hepatoma and platelets. J Biol Chem 1998; 273: 18770–18777.

    Article  CAS  PubMed  Google Scholar 

  • Rapraeger AC. The coordinated regulation of heparan sulfate syndecans and cell behavior. Curr Opin Cell Biol 1993; 5: 844–853.

    Article  CAS  PubMed  Google Scholar 

  • Saiki I, Murata J, Nakajima M, Tokura S, Azuma I. Inhibition by sulfated chitin derivatives of invasion through extracellular matrix and enzymatic degradation by metastatic melanoma cells. Cancer Res 1990; 50: 3631–3637.

    CAS  PubMed  Google Scholar 

  • Sivaram P, Obunike JC, Goldberg IJ. Lysolecithin-induced alteration of subendothelial heparan sulfate proteoglycans increases monocyte binding to matrix. J Biol Chem 1995; 270: 29760–29765.

    Article  CAS  PubMed  Google Scholar 

  • Stetler-Stevenson WG. Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Invest 1999; 103: 1237–1241.

    Article  CAS  PubMed  Google Scholar 

  • Toyoshima M, Nakajima M. Human heparanase. Purification characterization cloning and expression. J Biol Chem 1999; 274: 24153–24160.

    Article  CAS  PubMed  Google Scholar 

  • Vlodavsky I, Bar-Shavit R, Ishai-Michaeli R, Bashkin P, Fuks Z. Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism? Trends Biochem Sci 1991; 16: 268–271.

    Article  CAS  PubMed  Google Scholar 

  • Vlodavsky I, Bar-Shavit R, Korner G, Fuks Z. Extracellular matix-bound growth factors enzymes and plasma proteins. In: Rohrbach DH, Timpl R (eds), Basement Membranes: Cellular and Molecular Aspects. Academic Press Inc, Orlando, FL, 1993, pp. 327–343.

    Google Scholar 

  • Vlodavsky I, Eldor A, Haimovitz-Friedman A, Matzner Y, Ishai-Michaeli R, Lider O, Naparstek Y, Cohen IR, Fuks Z. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis 1992; 12: 112–127.

    CAS  PubMed  Google Scholar 

  • Vlodavsky I, Elkin M, Pappo O, Aingorn H, Atzmon R, Ishai-Michaeli R, Aviv A, Pecker I, Friedmann Y. Mammalian heparanase as mediator of tumor metastasis and angiogenesis. Is Med Assoc J 2000; 2: 37–45.

    Google Scholar 

  • Vlodavsky I, Friedmann Y. Molecular properties and function of heparanase in cancer metastasis and angiogenesis. J Clin Invest 2001; 108; 341–347.

    Article  CAS  PubMed  Google Scholar 

  • Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, Ishai-Michaeli Bitan M, Pappo, O, Peretz T, Michal I, Spector L, Pecker I. Mammalian heparanase: gene cloning expression and function in tumor progression and metastasis. Nat Med 1999; 5: 793–802.

    Article  CAS  PubMed  Google Scholar 

  • Vlodavsky I, Fuks Z, Bar-Ner M, Ariav Y, Schirrmacher V. Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis. Cancer Res 1983; 43: 2704–2711.

    CAS  PubMed  Google Scholar 

  • Vlodavsky I, Miao H-Q, Benezra M, Lidaer O, Bar-Shavit R, Schmidt A, Peretz T. Involvement of the extracellular matrix heparan sulfate proteoglycans and heparan sulfate degrading enzymes in angiogenesis and metastasis. In: Lewis CE, Bicknell R, Ferrara N (eds), Tumor Angiogenesis. Oxford University Press, Oxford, UK, 1997, pp. 125–140.

    Google Scholar 

  • Vlodavsky I, Miao HQ, Medalion B, Danagher P, Ron D. Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Metastasis Rev 1996; 15: 177–186.

    Article  CAS  PubMed  Google Scholar 

  • Vlodavsky I, Mohsen M, Lider O, Svahn CM, Ekre HP, Vigoda M, Ishai-Michaeli R, Peretz T. Inhibition of tumor metastasis by heparanase inhibiting species of heparin. Invasion Metastasis 1994; 14: 290–302.

    CAS  PubMed  Google Scholar 

  • Walch ET, Albino AP, Marchetti D. Correlation of overexpression of the low-affinity p75 neurotrophin receptor with augmented invasion and heparanase production in human malignant melanoma cells. Int J Cancer 1999; 82: 112–120.

    Article  CAS  PubMed  Google Scholar 

  • Weiss RE, Liu BC, Ahlering T, Dubeau L, Droller MJ. Mechanisms of human bladder tumor invasion: role of protease cathepsin B. J Urol 1990; 144: 798–804.

    CAS  PubMed  Google Scholar 

  • Wight TN. Cell biology of arterial proteoglycans. Arteriosclerosis 1989; 9: 1–20.

    CAS  PubMed  Google Scholar 

  • Wight TN, Kinsella MG, Qwarnstrom EE. The role of proteoglycans in cell adhesion migration and proliferation. Curr Opin Cell Biol 1992; 4: 793–801.

    Article  CAS  PubMed  Google Scholar 

  • Yanagishita M. Inhibition of intracellular degradation of proteoglycans by leupeptin in rat ovarian granulosa cells. J Biol Chem 1985; 260: 11075–11082.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology, Hadassah-Hebrew University Hospital, Jerusalem, 91120, Israel

    I. Vlodavsky, Y. Friedmann & M. Elkin

  2. Vascular Biology Research Center, the Bruce Rappaport Faculty of Medicine, Technion, Haifa, 31096, Israel

    I. Vlodavsky

  3. Department of Pathology, Hadassah-Hebrew University Hospital, Jerusalem, 91120, Israel

    O. Pappo

  4. Insight Ltd., Rabin Science Park, Rehovot, 76100, Israel

    I Pecker

  5. Division of Immunology and Cell Biology, John Curtin School of Medical Research, ANU Canberra, ACT, 2601, Australia

    M. D. Hulett, C. R. Parish & C. Freeman

Authors
  1. I. Vlodavsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y. Friedmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Elkin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. O. Pappo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. I Pecker
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. D. Hulett
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C. R. Parish
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. C. Freeman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Laboratoire de Biologie des Tumeurs et du Développement, Faculté de Médecine Université de Liège, Belgium

    Jean-Michel Foidart

  2. Department of Pathology & Laboratory Medicine, University of Pennsylvania, USA

    Ruth J. Muschel

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Vlodavsky, I. et al. (2002). Mammalian Heparanase: Molecular Properties, Inhibition and Involvement in Tumor Metastasis and Angiogenesis. In: Foidart, JM., Muschel, R.J. (eds) Proteases and Their Inhibitors in Cancer Metastasis. Cancer Metastasis — Biology and Treatment, vol 4. Springer, Dordrecht. https://doi.org/10.1007/1-4020-2008-2_12

Download citation

  • DOI: https://doi.org/10.1007/1-4020-2008-2_12

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-1-4020-0923-5

  • Online ISBN: 978-1-4020-2008-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation